BRIEF-Cipher Pharmaceuticals announces Canadian launch of Beteflam
April 5 (Reuters) - Cipher Pharmaceuticals Inc
* Cipher pharmaceuticals announces canadian launch of beteflam
* Commonly reported adverse drug reactions that occurred in patients using beteflam were skin and subcutaneous tissue disorders
* Expect to continue growth with six products targeted for canadian market in 2016 and eight in 2017 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
© Thomson Reuters 2017 All rights reserved.